A comparative study of human and zebrafish glucocorticoid receptor activities of natural and pharmaceutical steroids.
human GR
pharmaceuticals
reporter cell lines
steroids
zebrafish GR
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
06
06
2023
accepted:
31
07
2023
medline:
4
9
2023
pubmed:
1
9
2023
entrez:
1
9
2023
Statut:
epublish
Résumé
The action of environmental steroids on the human glucocorticoid receptor (hGR) has been pointed out with the risk to impair physiological immune and metabolic processes regulated by this nuclear receptor. However, there is still a lack of mechanistic information regarding their ability to interact with GR in aquatic species. To investigate ligand activation differences between hGR and zebrafish GR (zfGR), we tested several natural and synthetic steroids using reporter cell lines expressing hGR or zfGR. Almost all the glucocorticoids tested (dexamethasone, cortisol, bimedrazol, medrol, cortivazol and fluticasone) are agonists of the two receptors with similar potencies. The dissociated glucocorticoids, RU24782 and RU24858 are agonists of both zfGR and hGR but with a better potency for the latter. On the other hand, the synthetic glucocorticoid forbimenol and the mineralocorticoid aldosterone are agonist on hGR but antagonist on zfGR. The other steroids tested, androgens and progestins, are all antagonists of both GRs with equal or lower potency on zfGR than on hGR. Surprisingly, the lower efficacy and potency on zfGR of aldosterone, forbimenol and the dissociated glucocorticoids is not related to their affinity for the receptors which would suggest that it could be related to less efficacious recruitment of coactivators by zfGR compared to hGR.
Identifiants
pubmed: 37654569
doi: 10.3389/fendo.2023.1235501
pmc: PMC10466050
doi:
Substances chimiques
Glucocorticoids
0
Receptors, Glucocorticoid
0
Aldosterone
4964P6T9RB
Steroids
0
Pharmaceutical Preparations
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1235501Informations de copyright
Copyright © 2023 Toso, Boulahtouf, Escande, Garoche and Balaguer.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Environ Sci Technol. 2018 May 1;52(9):5296-5307
pubmed: 29580053
Trends Endocrinol Metab. 2011 Mar;22(3):87-93
pubmed: 21196123
Toxicol Appl Pharmacol. 2017 Mar 15;319:69-79
pubmed: 28174120
Toxicol Sci. 2021 Oct 27;184(1):170-182
pubmed: 34165557
Toxicol Sci. 2005 Jan;83(1):136-48
pubmed: 15483189
Mol Endocrinol. 1997 Aug;11(9):1245-55
pubmed: 9259316
PLoS One. 2008;3(10):e3545
pubmed: 18958157
Trends Pharmacol Sci. 2013 Sep;34(9):518-30
pubmed: 23953592
J Allergy Clin Immunol. 2013 Nov;132(5):1033-44
pubmed: 24084075
J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):222-31
pubmed: 17045799
Toxicology. 2019 May 15;420:39-45
pubmed: 30951782
Nature. 2022 Jan;601(7893):460-464
pubmed: 34937942
J Steroid Biochem Mol Biol. 2010 May 31;120(2-3):69-75
pubmed: 20346397
Environ Int. 2019 Dec;133(Pt A):105133
pubmed: 31520960
Environ Sci Technol. 2020 Aug 4;54(15):9510-9518
pubmed: 32650635
Environ Toxicol Chem. 2020 Jan;39(1):189-199
pubmed: 31614391
J Steroid Biochem Mol Biol. 2005 Apr;94(5):383-94
pubmed: 15876404
Mol Pharmacol. 2014 Feb;85(2):226-36
pubmed: 24225022
Environ Int. 2019 Jun;127:420-429
pubmed: 30959307
Toxicol Appl Pharmacol. 2006 Oct 1;216(1):44-54
pubmed: 16750840
Nature. 2022 Jan;601(7893):465-469
pubmed: 34937936
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18578-18583
pubmed: 31439819
Toxicol Appl Pharmacol. 2014 Oct 1;280(1):60-9
pubmed: 25106122
PLoS One. 2013 Oct 29;8(10):e77997
pubmed: 24205060
Environ Sci Technol. 2021 Dec 21;55(24):16489-16501
pubmed: 34843233
Biochem Pharmacol. 2022 Apr;198:114951
pubmed: 35149051
Pharmacol Rev. 2006 Dec;58(4):782-97
pubmed: 17132855
Environ Int. 2020 Jan;134:105278
pubmed: 31711021
Water Res. 2018 Aug 1;139:10-18
pubmed: 29621713
Front Endocrinol (Lausanne). 2021 May 18;12:665521
pubmed: 34084152
Water Res. 2020 Oct 15;185:116247
pubmed: 32758789
Mol Cell Endocrinol. 2000 Feb 25;160(1-2):39-49
pubmed: 10715537
Toxicol Appl Pharmacol. 2019 Oct 1;380:114709
pubmed: 31415773